Purimin 18.75 mg (Phentermine Hydrochloride)

Adult dose

Adults: Administer 37.5 mg of phentermine hydrochloride orally once daily before breakfast or 1 ～ 2 hours after breakfast. Use the minimum effective dose, adjusting it individually to achieve an adequate response. For some patients, 18.75 mg once daily may be appropriate, while in some cases it may be preferable to take 18.75 mg twice daily. Avoid taking this medicine late in the evening because it may cause insomnia. This medicine should be administered for a short term (within 4 weeks). However, to reduce inappropriate use and risks associated with this medicine, treatment may be continued if the patient achieves satisfactory weight loss within the first 4 weeks (weight loss of at least 1.8 kg or weight loss considered satisfactory by both the physician and the patient).

This medication should not be used in conjunction with other appetite suppressants and should only be used alone for a short period. It is not recommended to take this medication with other drugs aimed at weight loss due to uncertain safety and effectiveness. If symptoms such as dyspnea, angina, syncope, or leg edema, which are early signs of primary pulmonary hypertension, appear while using this medication, the patient should immediately notify their doctor. This medication may be associated with valvular heart disease, although reported cases are rare when used alone. It should not be administered to patients with advanced atherosclerosis, cardiovascular disease, severe hypertension, pulmonary hypertension, hyperthyroidism, glaucoma, mental anxiety or agitation, or a history of substance abuse. Additionally, it should not be used in children under 16 years of age, pregnant women, or women who may become pregnant. Caution should be exercised when administering to patients with diabetes or mild hypertension, and insulin dosage adjustments may be necessary for diabetic patients. This medication can affect the central nervous system and may cause symptoms such as anxiety, dizziness, insomnia, and headaches, with rare cases of psychiatric seizures. Cardiovascular side effects such as palpitations and elevated blood pressure may also occur. In cases of overdose, severe anxiety, coma, seizures, blood pressure abnormalities, vomiting, and abdominal pain may occur, requiring immediate treatment. When using this medication for the first time, start with the lowest dose and stop if tolerance develops rather than increasing the dose. Caution is needed when driving or performing hazardous tasks. Avoid taking this medication with alcohol as harmful interactions may occur. Pregnant or nursing women should only use this medication under a doctor's judgment due to potential risks to the fetus or infant. This medication is classified as a controlled substance and may lead to abuse and dependence, requiring careful attention. It should be stored out of reach of children.

• Primary pulmonary hypertension
• regurgitant heart valve disease
• palpitations
• tachycardia
• hypertension
• hyperstimulation
• anxiety
• dizziness
• insomnia
• discomfort

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. The ideal storage temperature is between 1 to 30 degrees Celsius (room temperature). Proper storage will help maintain the medication's effectiveness.

Appearance

Pink kidney-shaped tablet

Package unit

30 tablets/bottle, 100 tablets/bottle